We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$149M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$105M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$97.9M |
| 4 |
MPLX
MPLX
|
+$74.6M |
| 5 |
DCP
DCP Midstream, LP
DCP
|
+$63.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Midstream Partners
WES
|
+$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$338M |
| 3 |
Williams Companies
WMB
|
+$35.8M |
| 4 |
ExxonMobil
XOM
|
+$29.6M |
| 5 |
Verizon
VZ
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
801
DELISTED
Walgreens Boots Alliance
WBA
| $207K | ﹤0.01% |
4,617
-470,985
| -99% | -$23.2M |
|
802
Service Corp International
SCI
$11.5B
| $202K | ﹤0.01% |
3,065
-6,924
| -69% | -$436K |
|
803
Ford
F
$58.2B
| $199K | ﹤0.01% |
11,791
-3,663
| -24% | -$69.7K |
|
804
O-I Glass
OI
$1.43B
| $199K | ﹤0.01% |
15,076
-4,689
| -24% | -$61.2K |
|
|
AVEO
805
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $197K | ﹤0.01% |
35,325
-4,450
| -11% | -$18.3K |
|
806
BioAtla
BCAB
$5.63M
| $191K | ﹤0.01% |
764
-89
| -10% | -$37.2K |
|
|
EFTR
807
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $187K | ﹤0.01% |
1,861
-217
| -10% | -$28.8K |
|
808
PDS Biotechnology
PDSB
$38.3M
| $181K | ﹤0.01% |
29,221
-3,685
| -11% | -$22.9K |
|
809
CytomX Therapeutics
CTMX
$725M
| $179K | ﹤0.01% |
67,211
-8,302
| -11% | -$31.9K |
|
810
Dianthus Therapeutics
DNTH
$5.81B
| $175K | ﹤0.01% |
3,777
-474
| -11% | -$25.9K |
|
811
SunCoke Energy
SXC
$767M
| $171K | ﹤0.01% |
19,195
-5,967
| -24% | -$47K |
|
812
SAB Biotherapeutics
SABS
$266M
| $170K | ﹤0.01% |
4,508
-523
| -10% | -$24.1K |
|
813
NGL Energy Partners
NGL
$1.89B
| $164K | ﹤0.01% |
73,724
+12,334
| +20% | +$27.6K |
|
814
Atossa Therapeutics
ATOS
$24M
| $163K | ﹤0.01% |
8,676
-1,093
| -11% | -$22.2K |
|
815
INmune Bio
INMB
$46M
| $155K | ﹤0.01% |
18,363
-2,287
| -11% | -$20.5K |
|
|
CKPT
816
DELISTED
Checkpoint Therapeutics
CKPT
| $152K | ﹤0.01% |
8,609
-1,085
| -11% | -$23.3K |
|
|
IMPL
817
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $151K | ﹤0.01% |
23,675
-2,987
| -11% | -$22.6K |
|
818
Archrock
AROC
$6.28B
| $148K | ﹤0.01% |
16,088
-5,004
| -24% | -$42.8K |
|
|
SURF
819
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $142K | ﹤0.01% |
48,267
-5,121
| -10% | -$17.9K |
|
820
Fortress Biotech
FBIO
$109M
| $139K | ﹤0.01% |
6,827
-859
| -11% | -$23.5K |
|
821
CoreCivic
CXW
$3.09B
| $126K | ﹤0.01% |
11,248
-3,492
| -24% | -$34.2K |
|
822
Spyre Therapeutics
SYRE
$8.77B
| $117K | ﹤0.01% |
2,029
-254
| -11% | -$21.3K |
|
823
Tonix Pharmaceuticals
TNXP
$166M
| $117K | ﹤0.01% |
1
| – | – |
|
824
Acco Brands
ACCO
$382M
| $115K | ﹤0.01% |
14,354
-4,464
| -24% | -$37K |
|
825
Cardiff Oncology
CRDF
$65M
| $110K | ﹤0.01% |
44,511
-4,048
| -8% | -$14.3K |
|
Similar funds
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ALPS Advisors held 1,043 positions worth $9.22B, up 3.7% from $8.89B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
ALPS Advisors withdrew a net $371M in Q1 2022, closing 210 positions and reducing 486 holdings. Its most notable exit was Western Midstream Partners, an estimated $541M position sold in full.
By sector, the portfolio is most concentrated in Energy at 66% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ALPS Advisors opened a new position in Lucid Motors worth $40.8M.
- ALPS Advisors's largest Q1 2022 buy was Lucid Motors: 160,553 shares worth $40.8M.
- ALPS Advisors added most to Hess Midstream in Q1 2022, an estimated $149M increase.
- ALPS Advisors's biggest Q1 2022 reduction was Williams Companies, cutting an estimated $35.8M.
- ALPS Advisors fully exited Western Midstream Partners in Q1 2022, selling an estimated $541M.
- ALPS Advisors's ten largest holdings make up 56% of its $9.22B portfolio in Q1 2022.
- ALPS Advisors opened 155 new positions and closed 210 in Q1 2022.
- ALPS Advisors's portfolio value rose 3.7% quarter-over-quarter to $9.22B.
Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.